Annovis Bio, Inc. ANVS revenue by segment, product and geography
Annovis Bio, Inc.'s fiscal year ending 2025-12-31 carries a reported breakdown by geographies.
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filingThe latest 10-K carries no single-axis revenue breakdown; the quarter below is the only reported split.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.